Company intelligence / Profile preview

NIRLAB

Magdeburg, Saxony-Anhalt, Germanynirlab.com ↗

Ownership: Private
Development stage: Commercial

Overview

NIRLAB has demonstrated that its portable near-infrared spectroscopy devices can achieve lab-grade precision in substance identification. The system is ISO 17025 certified. In independent studies, the technology accurately identified methamphetamine and cocaine specimens with 96–98% accuracy within ±15% quantification uncertainty limits. The platform supports rapid field decisions by law enforcement and other sectors.

Therapeutic areas: Psychiatry
Modalities: Device (Handheld near-infrared spectroscopy)
Industry: Metabolite Diagnostics

Partnerships

Australian Federal Police Forensics Division (AFP)University of Technology Sydney (UTS)Warsash Scientific

Beyond the preview

Go deeper on NIRLAB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NIRLAB.

Explore the full profile